YKL‐40, a Matrix Protein of Specific Granules in Neutrophils, Is Elevated in Serum of Patients with Community‐Acquired Pneumonia Requiring Hospitalization

Citations Over Time

Abstract

The serum concentration of YKL-40, a matrix protein of specific granules in neutrophils, was determined by RIA in 90 patients hospitalized with pneumonia of suspected bacterial origin. Of these, 64 were followed prospectively during antibiotic treatment with blood samples taken on day 0 (on admission and the start of treatment) and on days 1, 3, 5, 7, 10, and 21. Serum YKL-40 at admission was increased in patients with Streptococcus pneumoniae pneumonia (median, 893 microgram/L; 95% confidence interval [CI], 704-1560), compared with healthy subjects (median, 102 microgram/L; 95% CI, 64-247 microgram/L; P<.001) and in patients with pneumonia of unknown etiology (median, 448 microgram/L; 95% CI, 334-700; P<.05). Peak YKL-40 serum values were observed on day 1 and thereafter declined steeply to almost normal by day 3. During the first 10 days, there was a close relation between serum YKL-40 and markers of specific granules of neutrophils (serum lactoferrin and neutrophil gelatinase-associated lipocalin), which suggests that serum YKL-40 reflects exocytosis of specific granules of neutrophils in persons with acute bacterial pneumonia.

Related Papers

• → Longitudinal Analysis of Pneumococcal Antibodies during Community-Acquired Pneumonia Reveals a Much Higher Involvement of Streptococcus pneumoniae than Estimated by Conventional Methods Alone(2011)28 cited
• → The Role of Pneumococcal Pneumonia among Community-Acquired Pneumonia in Adult Turkish Population: TurkCAP Study(2021)6 cited
• → ANALYSIS OF THEEFFECTIVENESS OF THE IMPLEMENTATION OF THE PILOT PROJECT OFVACCINATION AGAINST PNEUMOCOCCAL INFECTION IN RISK GROUPS INTHE MUNICIPALITIES LEADING ON INDICATORS OF MORTALITY FROMCOMMUNITY-ACQUIRED PNEUMONIA(2018)2 cited
• → Should all the bacteremic pneumococcal pneumonia patients be considered severe Community-Acquired Pneumonia?(2004)
• Clinical value of procalcitonin and C-reactive protein in community acquired bacterial pneumonia(2014)